100% Quality Guarantee
PhD-Level Technical Support
Key Features

FITC Anti-Human CD37 Antibody [IPO-24] (AGEL1017)

SKU AGEL1017
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Human
Applications FC
€113 - €428

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

FITC Anti-Human CD37 Antibody [IPO-24]

The Human CD37 Monoclonal Antibody FITC-conjugated (IPO-24) is a specialized tool for researchers studying CD37, a protein found on the surface of human cells that plays a key role in immune system function. This monoclonal antibody, conjugated with FITC for fluorescence detection, is produced for use in various immunological research applications.CD37 is a transmembrane glycoprotein known to be involved in B-cell signaling and activation, making it a vital target for investigations in immunology and cancer biology. By specifically binding to CD37, this antibody allows for precise identification and analysis of CD37-expressing cells in diverse experimental settings.

Its FITC conjugation enhances visualization and tracking of CD37-positive cells, enabling detailed studies on their behavior and function.Researchers exploring immune cell interactions, signal transduction pathways, and disease mechanisms rely on tools like the Human CD37 Monoclonal Antibody FITC-conjugated (IPO-24) to advance their understanding of immune responses and develop potential therapeutic strategies. With its proven specificity and versatility, this antibody is a valuable asset for uncovering the intricacies of CD37 biology and its implications in health and disease.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose